WATERTOWN, MA, Tarveda Therapeutics, Inc., formerly Blend Therapeutics, today announced that it has secured $38 million in Series C financing. Read More
MENLO PARK, CA, Biopharmaceutical company focused on the development of next-generation cell immunotherapies, announced today that it closed a $51 million Series A financing. Read More
LOS ANGELES, CA, Healthcare IT company SnapMD, Inc., announced today it completed the first closing of its Series A funding in the amount of $5.3 million. Read More
NEW YORK, NY, Leading content marketing platform in financial services headquartered in New York City, today announced a Series A round of funding. Read More